CoV-GLUEGenomeCountriesLineagesMutationsInsertionsDeletionsUpdated:

CoV-GLUE | Mutations | Mutation

CoV-GLUE Mutation: ORF = N : CodonNum = 217 & Codon = gcA

Details of the codons used for the mutation across all lineages (CodonProp is the proportion each codon is used for this AA mutation):

ORFCodonNumMutORF1abMutMutTypeRefCodonMutCodonAACountCodonCountCodonPropGenome Position
N217A217AsyngcTgcA6401110.17343828922-28924

Details of the mutation no within lineages (LineageCodonProp is the proportion the codon is observed at, at this particular site, on each lineage):

ORFCodonNumMutRefCodonMutCodonCodonCountAACountLineageLineageCodonProp
N217A217AgcTgcA111640All0.000021
N217A217AgcTgcA2163AY.440.000012
N217A217AgcTgcA1387B.1.1.70.000012
N217A217AgcTgcA159B.1.4290.000024
N217A217AgcTgcA229B.1.20.000018
N217A217AgcTgcA2021B.1.1600.000624
N217A217AgcTgcA317B.1.617.20.000011
N217A217AgcTgcA113AY.200.000039
N217A217AgcTgcA413AY.40.000006
N217A217AgcTgcA413B.1.1770.000053
N217A217AgcTgcA1212AY.290.000189
N217A217AgcTgcA1010AY.1160.002868
N217A217AgcTgcA36B.10.000027
N217A217AgcTgcA25AY.250.000012
N217A217AgcTgcA15AY.30.00001
N217A217AgcTgcA55B.1.177.860.000917
N217A217AgcTgcA24AY.1200.000074
N217A217AgcTgcA24AY.90.000135
N217A217AgcTgcA14B.1.10.000018
N217A217AgcTgcA23AY.330.000134
N217A217AgcTgcA23B.1.3510.000059
N217A217AgcTgcA22AY.340.000194
N217A217AgcTgcA22B.1.5640.000852
N217A217AgcTgcA22B.1.564.10.003155
N217A217AgcTgcA11AY.260.000028
N217A217AgcTgcA11AY.5.40.000277
N217A217AgcTgcA11B.1.1.3050.003861
N217A217AgcTgcA11B.1.1.4340.000349
N217A217AgcTgcA11B.1.1.700.000341
N217A217AgcTgcA11B.1.160.300.002976
N217A217AgcTgcA11B.1.5260.000024
N217A217AgcTgcA11B.1.6090.000479
N217A217AgcTgcA11B.1.6210.000089
N217A217AgcTgcA11C.370.000116
N217A217AgcTgcA11P.1.150.000232
N217A217AgcTgcA11P.30.001595
N217A217AgcTgcA11R.10.00009

CoV-GLUE is still in development. CoV-GLUE was originally developed as part of COG-UK by Josh Singer using the GLUE framework at the MRC-University of Glasgow Centre for Virus Research (CVR). In 2021 it was redeveloped by Richard Orton to scale to the millions of genome sequences available. We acknowledge support from the MRC (MC_UU_12014/12), WT (220977/Z/20/Z) and UKRI G2P (MR/W005611/1). Please contact Richard Orton with any queries: Richard.Orton@glasgow.ac.uk

CoV-GLUE uses sequence data from GISAID. GISAID data provided via this web application is subject to GISAID's Terms and Conditions.